Patient advocacy groups and professional associations often work together in coalitions to advance common goals. What is an appropriate role for pharmaceutical companies to play in these coalitions?
The Fall 2013 Edition of STAR: Successfully Targeting Advocacy Relations surveyed patient advocacy groups and professional associations across 15 therapeutic areas about their experiences and views on working in coalitions.
The data reveal:
- A large majority of organizations – 87% – have been members of three or more coalitions in the past three years
- Most coalitions are focused on disease awareness and education, policy action, and advocacy group support
- Panelists believe there are many appropriate roles for pharmaceutical companies to play in coalitions, including providing financial support, connecting organizations together, and providing resources
The STAR report is a syndicated market research report allowing pharmaceutical and biotech companies to benchmark their company’s advocacy relations efforts. STAR will help companies understand emerging policy and advocacy trends, enabling companies to quickly develop, commercialize, differentiate, and secure reimbursement for products.
About Mark Krueger & Associates, Inc.
Since 1995, Mark Krueger & Associates, Inc. has been a leader in health care constituency relations. Clients include global research and development based pharmaceutical companies as well as biotechnology and health care device and diagnostic companies. Mark Krueger & Associates focuses on establishing and enhancing partnerships between companies and the diverse groups that influence the success of their products.
About The Brooks Group
Since 1996, The Brooks Group has been providing customized market research, management consulting, strategic planning, and business skills training, to a variety of different functions and roles within pharmaceutical and biotech companies, with specific expertise and competencies in sales and marketing for managed markets.